deoxyuridine has been researched along with EBV Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra Jha, H; Indari, O; Kumar, S; Murmu, S; Tiwari, D | 1 |
1 other study(ies) available for deoxyuridine and EBV Infections
| Article | Year |
|---|---|
Targeting Epstein-Barr Virus dUTPase, an Immunomodulatory Protein Using Antiviral, Anti-Inflammatory, and Neuroprotective Phytochemicals.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Deoxyuridine; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Ligands; Nucleotides; Phytochemicals; Pyrophosphatases | 2022 |